Drug Trial Radar · NCT04411641
Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES)
Last checked: Nov 20, 2026Latest source record: Jul 2, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,131
Actual
Start
Sep 24, 2020
Primary completion
Aug 29, 2024
Study completion Aug 29, 2024
Sponsor
- Lead sponsor
- SanofiSanofi (SNY)
- Sponsor type
- Industry
- First posted
- Jun 2, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Primary Objective: To determine the efficacy of SAR442168 compared to placebo in delaying disability progression in NRSPMS Secondary Objective: To evaluate efficacy of SAR442168 compared to placebo on clinical endpoints, magnetic resonance imaging (MRI) lesions, cognitive performance, physical function, and quality of life To evaluate safety and tolerability of SAR442168 To evaluate population pharmacokinetics (PK) of SAR442168 and relevant metabolites in NRSPMS and its relationship to efficacy and safety To evaluate pharmacodynamics (PD) of SAR442168
Conditions
- Non-relapsing Secondary Progressive Multiple Sclerosis
Interventions
TolebrutinibDrug
Pharmaceutical form: Film-coated tablet Route of administration: Oral
Placebo to match TolebrutinibDrug
Pharmaceutical form: Film-coated tablet Route of administration: Oral
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to Onset of 6-Month Confirmed Disability Progression (CDP) as Assessed by Expanded Disability Status Scale (EDSS)Time frame: Baseline (Day 1) up to approximately 47 months
Locations
306 sites in 31 countries. Site status is shown where the registry gives one.
University of Alabama MS Center-Site Number:8400013
Birmingham, Alabama
Center for Neurology and Spine-Site Number:8400089
Phoenix, Arizona
Arcadia Neurology Center-Site Number:8400070
Arcadia, California
UC San Diego ACTRI-Site Number:8400101
La Jolla, California
Collaborative Neuroscience Research-Site Number:8400045
Long Beach, California
Multiple Sclerosis Center-Site Number:8400143
Los Angeles, California
University of San Francisco, Sandler Neurosciences Center-Site Number:8400137
San Francisco, California
Harbor UCLA-Site Number:8400088
Torrance, California
Regina Berkovich, MD, PhD-Site Number:8400059
West Hollywood, California
Mountain Neurological Research Center, Inc.-Site Number:8400128
Basalt, Colorado
University of Colorado-Site Number:8400012
Denver, Colorado
Advanced Neurosciences Research-Site Number:8400025
Fort Collins, Colorado
South Florida Neurology Associates-Site Number:8400029
Boca Raton, Florida
Neurology Associates, PA-Site Number:8400004
Maitland, Florida
Aqualane Clinical Research-Site Number:8400027
Naples, Florida
Axiom Clinical Research of Florida-Site Number:8400001
Tampa, Florida
University of South Florida-Site Number:8400006
Tampa, Florida
Meridian Clinical Research-Site Number:8400003
Savannah, Georgia
Consultants In Neurology-Site Number:8400011
Northbrook, Illinois
University of Kansas Medical Center-Site Number:8400023
Kansas City, Kansas
CHI Saint Joseph Medical Group Neurology-Site Number:8400110
Lexington, Kentucky
Tufts Medical Center-Site Number:8400072
Boston, Massachusetts
University of Massachusetts-Site Number:8400014
Worcester, Massachusetts
Wayne State University-Site Number:8400046
Detroit, Michigan
The Memorial Hospital-Site Number:8400033
Owosso, Michigan
Minneapolis Clinic of Neurology-Site Number:8400051
Minneapolis, Minnesota
Mayo Clinic-Site Number:8400111
Rochester, Minnesota
Missouri Baptist Medical Center-Site Number:8400019
St Louis, Missouri
Lou Ruvo Center for Brain Health-Site Number:8400117
Las Vegas, Nevada
Holy Name Hospital-Site Number:8400104
Teaneck, New Jersey
University of New Mexico-Site Number:8400032
Albuquerque, New Mexico
Icahn School of Medicine at Mount Sinai (Department of Endoc-Site Number:8400038
New York, New York
Neurology Associates of Stony Brook-Site Number:8400042
Stony Brook, New York
Meridian Clinical Research, LLC-Site Number:8400005
Raleigh, North Carolina
Sanford Brain & Spine Center-Site Number:8400126
Fargo, North Dakota
University Hospitals CMC-Site Number:8400083
Cleveland, Ohio
Cleveland Clinic-Site Number:8400125
Cleveland, Ohio
Optimed Research, LTD-Site Number:8400147
Columbus, Ohio
Neurology Specialists-Site Number:8400002
Dayton, Ohio
Columbus Neuroscience-Site Number:8400010
Westerville, Ohio
Showing 40 of 306 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.